Lidocaine Medication Information
Get detailed information on Lidocaine, including pronunciation, uses, dosage guidelines, indications, and instructions on how and when to take it and when to avoid it.
The updated prescription information on Lidocaine provides an overview of possible side effects, precautions, warnings, and storage tips.
You'll also find brand names used in india and internationally, along with pricing details. For further clarification, consult your healthcare provider.
Generic Name : Lidocaine Pronunciation : Lye-do-cane Therapeutic Classification : VasopressorsTrade Names/Brand Names of Lidocaine
India :
Relaxyl Spray (1.16% w/w / 2% w/w /5% w/w /3% w/w /10% w/w /5% w/w) |
Lignocin 2% (21.3mg/mL) |
Asthesia |
Gesicain 2% Jelly |
Xylocaine Viscous (21.3mg/mL) |
Xylocard 2% (21.3mg/mL) |
Surfaz DPS |
Candid-O |
Prilox (5 gm) |
Xymoheal Spray (2%/1%/5%/10%/3%/5%)
International :
Xylocaine Viscous.
Why is Lidocaine Prescribed? (Indications)
This medication is a local anesthetic, indicated for local or regional anesthesia. It prevents nerves from sending painful impulses to the brain.When should Lidocaine not be taken? (Contraindications)
Hypersensitivity.What is the dosage of Lidocaine?
IV/IM- 50 – 100mg bolus injection followed by 20 – 40mg every 10 -20 min or 1 – 3mg/min infusion.Topical- Surface anesthetic: As eutectic mixture containing lidocaine base 2.5% and prilocaine base 2.5%: Apply to skin under an occlusive dressing before procedure.
How should Lidocaine be taken?
It comes as a solution for injection to be administered by a healthcare provider into the vein or muscle.It also comes as a cream, gel, and solution to apply topically.
What are the warnings and precautions for Lidocaine?
• Caution needed for pregnant and breastfeeding women.• It may cause dizziness, drowsiness or blurred vision, do not drive a car or operate machinery while taking this medication.
What are the side effects of Lidocaine?
Dizziness, drowsiness, vomiting, blurred vision and slurred speech.♦ Anaphylactic reactions.
